For HMOX1 and SOD1, significant upregulation was less consistently achieved by Nrf2 activators, although all except MMF demonstrated significant upregulation of SOD1 in COPD patients. The gene discussed is HMOX1; the disease is chronic obstructive pulmonary disease.